[1] |
YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan.
Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes
[J]. Chinese General Practice, 2025, 28(24): 3053-3058.
|
[2] |
HAN Bing, DU Shuzhen, MENG Xiaoxue, ZHANG Lu, CHEN Zixian, TENG Fengling.
Plasma Periostin Levels Correlated with Myocardial Fibrosis in Patients with Heart Failure with Different Ejection Fraction
[J]. Chinese General Practice, 2025, 28(24): 2979-2984.
|
[3] |
LIU Yinyin, SUI Hongping, LI Tingting, JIANG Tongtong, SHI Tieying, XIA Yunlong.
Advances in Risk Prediction Models for Cardiotoxicity Associated with Breast Cancer Treatment
[J]. Chinese General Practice, 2025, 28(24): 3072-3078.
|
[4] |
JIANG Shihua, ZHU Zheng, REN Yingying, ZHU Yaolei, WANG Yue, GAO Xibin.
Meta Analysis of the Prevalence and Risk Factors of Myopia in Chinese Children and Adolescents
[J]. Chinese General Practice, 2025, 28(24): 3043-3052.
|
[5] |
LI Hao, LI Jiangtao, LIU Dan, WANG Jianjun.
Efficacy and Safety of Belimumab, Anifrolumab, and Telitacicept on the Treatment of Systemic Lupus Erythematosus: a Network Meta-analysis
[J]. Chinese General Practice, 2025, 28(23): 2924-2933.
|
[6] |
WANG Xiaolin, LI Qiuyue, ZHOU Yanjun, ZHANG Jinhui, LIANG Tao.
Incidence and Risk of Cardiovascular Toxicity with Fruquintinib in Metastatic Colorectal Cancer: a Meta-analysis
[J]. Chinese General Practice, 2025, 28(23): 2934-2940.
|
[7] |
ZHOU Qian, WU Xiaomin, WANG Baohua, YAN Ruohan, YU Miao, WU Jing.
Study on Nomogram Prediction Model for Risk of Gastric Cancer
[J]. Chinese General Practice, 2025, 28(23): 2870-2877.
|
[8] |
WANG Jiuge, ZHAN Wuyi, HE Anxia.
The Impact of Early Microcirculation Perfusion after Percutaneous Coronary Intervention for Acute Myocardial Infarction on Left Ventricular Function
[J]. Chinese General Practice, 2025, 28(23): 2878-2884.
|
[9] |
ZHAO Xiaoqing, GUO Tongtong, ZHANG Xinyi, LI Linhong, ZHANG Ya, JI Lihong, DONG Zhiwei, GAO Qianqian, CAI Weiqing, ZHENG Wengui, JING Qi.
Construction and Validation of a Risk Prediction Model for Cognitive Impairment in Community-dwelling Older Adults
[J]. Chinese General Practice, 2025, 28(22): 2776-2783.
|
[10] |
DONG Haocheng, HAO Xiao, AN Dong, LI Haohan, LI Shuren.
Research Progress of Heart Failure with Supra-normal Ejection Fraction
[J]. Chinese General Practice, 2025, 28(21): 2692-2696.
|
[11] |
MA Panpan, WANG Sijing, YOU Na, DING Dafa, LU Yibing.
Efficacy and Safety of Danuglipron and Orforglipron in the Treatment of Type 2 Diabetes Mellitus: a Meta-analysis
[J]. Chinese General Practice, 2025, 28(21): 2679-2685.
|
[12] |
HU Wanqin, YU Shenyan, CAO Xuehua, XIANG Feng, JIA Yu.
Factors Associated with Precocious Puberty in Chinese Children: a Meta-analysis
[J]. Chinese General Practice, 2025, 28(21): 2661-2671.
|
[13] |
ADILI Tuersun, CHENG Gang.
Meta-analysis of the Efficacy and Safety of Finerenone in the Treatment of Type 2 Diabetic Nephropathy
[J]. Chinese General Practice, 2025, 28(21): 2686-2691.
|
[14] |
GUO Shengteng, ZHANG Fenfen, WAN Di, YU Dongmei, WANG Qinghua.
Risk Factors for Severe Acute Pancreatitis Complicated with Acute Lung Injury: a Meta-analysis
[J]. Chinese General Practice, 2025, 28(20): 2546-2554.
|
[15] |
ZHANG Bingqing, WANG Zhongkai, WU Changyong, SUN Huang, LI Ruijie, LIU Wenjie, LUO Yihua, ZHENG Lihui, PENG Yunzhu.
Changes and Trend Prediction in the Global Burden of Congenital Heart Defects, 1990-2021
[J]. Chinese General Practice, 2025, 28(18): 2253-2261.
|